Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-29

Clinical Trial Update: A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial updating safety and efficacy results for a single-dose UBX0101 in knee osteoarthritis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UBX0101

Snippet

Sponsor: Unity Biotechnology, Inc. | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED | Results posted: 2021-12-29